These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39086528)

  • 41. Development of a Chimeric Protein BiPPB-mIFNγ-tTβRII for Improving the Anti-Fibrotic Activity in Vivo by Targeting Fibrotic Liver and Dual Inhibiting the TGF-β1/Smad Signaling Pathway.
    Dong Y; Wang X; Xu L; Li X; Dai H; Mao X; Chu Y; Yuan X; Liu H
    Protein J; 2023 Dec; 42(6):753-765. PubMed ID: 37690089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
    Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
    J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
    Verrecchia F; Mauviel A
    J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
    Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
    Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl
    Mohseni R; Karimi J; Tavilani H; Khodadadi I; Hashemnia M
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):163-171. PubMed ID: 30706740
    [No Abstract]   [Full Text] [Related]  

  • 46. REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway.
    Cho SS; Lee JH; Kim KM; Park EY; Ku SK; Cho IJ; Yang JH; Ki SH
    Free Radic Biol Med; 2021 Nov; 176():246-256. PubMed ID: 34614448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting the transforming growth factor-beta signaling pathway in human cancer.
    Nagaraj NS; Datta PK
    Expert Opin Investig Drugs; 2010 Jan; 19(1):77-91. PubMed ID: 20001556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.
    Shirasaki T; Honda M; Shimakami T; Murai K; Shiomoto T; Okada H; Takabatake R; Tokumaru A; Sakai Y; Yamashita T; Lemon SM; Murakami S; Kaneko S
    Hepatology; 2014 Nov; 60(5):1519-30. PubMed ID: 24962339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.
    Matsuzaki K
    Cell Tissue Res; 2012 Jan; 347(1):225-43. PubMed ID: 21626291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viruses as key modulators of the TGF-β pathway; a double-edged sword involved in cancer.
    Mirzaei H; Faghihloo E
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29345394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathways.
    Liu X; Wang X; Xu L; Fan J; Yuan Q; Zhang F; Liu J; Qiu X; Li Y; Xia C; Liu H
    Eur J Pharmacol; 2024 Aug; 977():176708. PubMed ID: 38843945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.
    Deng YL; Xiong XZ; Cheng NS
    Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):467-78. PubMed ID: 23060391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling.
    Song Y; Wei J; Li R; Fu R; Han P; Wang H; Zhang G; Li S; Chen S; Liu Z; Zhao Y; Zhu C; Zhu J; Zhang S; Pei H; Cheng J; Wu J; Dong L; Song G; Shen X; Yao Q
    Hepatology; 2023 Nov; 78(5):1433-1447. PubMed ID: 36800849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human-Induced Hepatocytes-Derived Extracellular Vesicles Ameliorated Liver Fibrosis in Mice Via Suppression of TGF-β1/Smad Signaling and Activation of Nrf2/HO-1 Signaling.
    Liu W; Wu J; Cao H; Ma C; Wu Z; Tian Y; Ma C; Qiu H; Pan G
    Stem Cells Dev; 2023 Oct; 32(19-20):638-651. PubMed ID: 37345718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.
    Iwanaga T; Chiba T; Nakamura M; Kaneko T; Ao J; Qiang N; Ma Y; Zhang J; Kogure T; Yumita S; Ishino T; Ogawa K; Kan M; Nakagawa M; Fujiwara K; Fujita N; Sakuma T; Kanzaki H; Koroki K; Kusakabe Y; Inoue M; Kobayashi K; Kanogawa N; Kiyono S; Kondo T; Nakagawa R; Ogasawara S; Nakamoto S; Muroyama R; Kato J; Kanda T; Maruyama H; Mimura N; Honda T; Murayama T; Nakamura H; Kato N
    Biochem Biophys Res Commun; 2023 Jan; 642():192-200. PubMed ID: 36586187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
    Lan HY
    Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanistic aspects of antifibrotic effects of honokiol in Con A-induced liver fibrosis in rats: Emphasis on TGF-β/SMAD/MAPK signaling pathways.
    Elfeky MG; Mantawy EM; Gad AM; Fawzy HM; El-Demerdash E
    Life Sci; 2020 Jan; 240():117096. PubMed ID: 31760097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.
    Sakai K; Jawaid S; Sasaki T; Bou-Gharios G; Sakai T
    Am J Pathol; 2014 Oct; 184(10):2611-7. PubMed ID: 25108224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease.
    Li Y; Fan W; Link F; Wang S; Dooley S
    JHEP Rep; 2022 Feb; 4(2):100397. PubMed ID: 35059619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.